Literature DB >> 10360234

The beta enolase subunit displays three different patterns of microheterogeneity in human striated muscle.

T Merkulova1, L E Thornell, G Butler-Browne, C Oberlin, M Lucas, N Lamandé, M Lazar, A Keller.   

Abstract

In higher vertebrates, the glycolytic enzyme enolase (2-phospho-D-glycerate hydrolyase; EC 4.2.1.11) is active as a dimeric protein formed from three subunits--alpha: ubiquitous, beta: muscle specific, and gamma: neuron specific--encoded by different genes. In the present study, we have shown that an antiserum previously produced against the mouse beta beta enolase is also a specific reagent for the muscle specific human enolase. Using this antiserum to study human muscles, we demonstrated novel patterns of the beta subunit microheterogeneity which are distinctive from those observed previously in rodents and which appear to be independent of age, gender and muscular activity. Two variants of the beta subunit differing by their size have been detected: one heavy form of 46 kDa (beta H) and one light form of 45 kDa (beta L). Muscle biopsies expressed either beta H or beta L or beta H + beta L, and all muscles of an individual expressed the same variants. The products of in vitro translation of RNA prepared from human muscle displayed beta subunit variants identical to those of the protein present in the biopsy. Therefore the differences observed between individuals reveal a difference already present at the level of the RNA transcripts. These observations suggest the existence of an yet undescribed polymorphism of the human beta enolase gene which could affect the coding sequence. Comparative immunocytochemical and histochemical analyses of biopsies demonstrated that the beta subunit was expressed in all fast fibres (type II), but not in slow fibres (type I). No difference was observed in the intensity of beta enolase immunolabelling between the various types (IIA, IIAB, IIB) of fast fibres. No significant difference in fibre type composition and histological appearance was visible between muscles presenting either one of the three patterns of microheterogeneity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360234     DOI: 10.1023/a:1005428328913

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  25 in total

1.  Modulation of embryonic and muscle-specific enolase gene products in the developing mouse hindlimb.

Authors:  M Lucas; C Goblet; A Keller; N Lamandé; F Gros; R G Whalen; M Lazar
Journal:  Differentiation       Date:  1992-09       Impact factor: 3.880

2.  Activation of the gene encoding the glycolytic enzyme beta-enolase during early myogenesis precedes an increased expression during fetal muscle development.

Authors:  A Keller; M O Ott; N Lamandé; M Lucas; F Gros; M Buckingham; M Lazar
Journal:  Mech Dev       Date:  1992-07       Impact factor: 1.882

3.  Structural changes in male trapezius muscle with work-related myalgia.

Authors:  F Kadi; G Hägg; R Håkansson; S Holmner; G S Butler-Browne; L E Thornell
Journal:  Acta Neuropathol       Date:  1998-04       Impact factor: 17.088

4.  Mobility of creatine phosphokinase and beta-enolase in cultured muscle cells.

Authors:  M Arrio-Dupont; G Foucault; M Vacher; A Douhou; S Cribier
Journal:  Biophys J       Date:  1997-11       Impact factor: 4.033

5.  Coexpression of alpha and gamma enolase genes in neurons of adult rat brain.

Authors:  A Keller; A Bérod; M Dussaillant; N Lamandé; F Gros; M Lucas
Journal:  J Neurosci Res       Date:  1994-08-01       Impact factor: 4.164

6.  Biochemical and immunological properties of the mouse brain enolases purified by a simple method.

Authors:  A Keller; H Scarna; A Mermet; J F Pujol
Journal:  J Neurochem       Date:  1981-04       Impact factor: 5.372

7.  Biochemical characterization of the mouse muscle-specific enolase: developmental changes in electrophoretic variants and selective binding to other proteins.

Authors:  T Merkulova; M Lucas; C Jabet; N Lamandé; J D Rouzeau; F Gros; M Lazar; A Keller
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

8.  Three slow myosin heavy chains sequentially expressed in developing mammalian skeletal muscle.

Authors:  S M Hughes; M Cho; I Karsch-Mizrachi; M Travis; L Silberstein; L A Leinwand; H M Blau
Journal:  Dev Biol       Date:  1993-07       Impact factor: 3.582

9.  In vitro posttranslational modification of lamin B cloned from a human T-cell line.

Authors:  K M Pollard; E K Chan; B J Grant; K F Sullivan; E M Tan; C A Glass
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

10.  Structural features of the human gene for muscle-specific enolase. Differential splicing in the 5'-untranslated sequence generates two forms of mRNA.

Authors:  A Giallongo; S Venturella; D Oliva; G Barbieri; P Rubino; S Feo
Journal:  Eur J Biochem       Date:  1993-06-01
View more
  2 in total

1.  The muscle-specific enolase is an early marker of human myogenesis.

Authors:  F Fougerousse; F Edom-Vovard; T Merkulova; M O Ott; M Durand; G Butler-Browne; A Keller
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

2.  Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity.

Authors:  Darci Phillips; Michiel Ten Hove; Jurgen E Schneider; Colin O Wu; Liam Sebag-Montefiore; Angel M Aponte; Craig A Lygate; Julie Wallis; Kieran Clarke; Hugh Watkins; Robert S Balaban; Stefan Neubauer
Journal:  J Mol Cell Cardiol       Date:  2009-11-11       Impact factor: 5.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.